Published in Health Insurance Law Weekly, December 25th, 2005
It is expected that a full patent infringement trial will take place in 2006, although no date has been set. Biaxin XL is indicated for respiratory tract infections.
Abbott is a broad-based healthcare company discovering, developing, manufacturing and marketing pharmaceuticals and medical products, including nutritionals, devices and diagnostics.
The company employs more than 60,000 people and markets its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.